Skip to main content
OpenTrials
Completed

NCT Number: NCT06518759

Effect of Glossopharyngeal Versus Diaphragmatic Breathing Exercise on Pulmonary Function After Decortication Surgery

This study will be conducted to compare between the effect of glossopharyngeal and diaphragmatic breathing exercises on pulmonary functions after decortication surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Disease Lung Diseases Respiratory Tract Diseases

Age range

40 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Mai Gamal El-Din Mostafa

Cairo, Egypt

About this study

Lung decortication is a well-known procedure for the treatment of empyema. Persistent lung collapse and non-expansion of the lung parenchyma are frequently noticed in the postoperative period after decortications, chest physiotherapy plays a crucial role in the re-expansion of underlying parenchyma.

There is an increased flow of patients after decortication surgery to hospitals who suffer from decreased lung volumes so the hospitalization period for them increases which puts an economical burden on health insurance services with a decreased level of quality of life that is the most concern to improve patient status and relieve this burden. So this study aims to improve patient's lung volumes and arterial blood gas parameters which improves patient status through two various forms of breathing exercises.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The participant's body mass index (BMI) will be ranged from 25- 29.9 kg/m2
  • The patient will receive treatment after 24 hours after decortication
  • The study will be in the intensive care unit (ICU).
  • The patients have unilateral lung decortication
  • Their vital capacity is 70% or less.

Exclusion criteria

  • Cancerous patient.
  • Inability to comprehend and follow instructions as in dementia
  • paralytic involvement of thorax muscle
  • Abdominal diseases that affect diaphragmatic function
  • Diaphragmatic paralysis

Treatment and study plan

traditional chest techniques

Other

patients will receive traditional chest techniques in the form of percussion and vibration, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks

Glossopharyngeal breathing exercise

Other

patients will receive Glossopharyngeal breathing exercise, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks.

Diaphragmatic breathing exercise

Other

patients will receive diaphragmatic breathing exercise, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks.

Primary outcomes

  1. Tidal volume

    Time frame: within 2 weeks

    The spirometer device (Meditech, made in China) will be used to measure tidal volume for all participants in all groups before and after the treatment program. It is the amount of air that moves in or out of the lungs with each respiratory cycle. It measures about 400 ml in a healthy female.

  2. Inspiratory reserve volume (IRV)

    Time frame: within 2 weeks

    The spirometer device (Meditech, made in China) will be used to measure inspiratory reserve volume (IRV) for all participants in all groups before and after the treatment program.

    • IRV: It is the amount of air that can be forcibly inhaled after normal tidal volume. The normal adult value is 1900-3300 ml.

  3. Expiratory reserve volume (ERV)

    Time frame: within 2 weeks

    The spirometer device (Meditech, made in China) will be used to measure expiratory reserve volume (ERV) for all participants in all groups before and after the treatment program.

    ERV: It is the amount of extra air above normal breath-exhaled during forceful breath out, its average is about 800ml in females.

  4. Measurement of the potential of hydrogen (PH)

    Time frame: within 2 weeks

    Blood gas analyzer will be used to measure the potential of hydrogen (PH) for all participants in all groups before and after the treatment program.

    The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.

    The normative value of pH is7.35-7.45

  5. Measurement of the partial arterial pressure of carbon dioxide(PaCO2)

    Time frame: within 2 weeks

    Blood gas analyzer will be used to measure the partial arterial pressure of carbon dioxide(PaCO2) for all participants in all groups before and after the treatment program.

    The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.

    the normative value of PaCO2 is 4.7-6 KPa.

  6. Measurement of the partial arterial pressure of oxygen (PaO2)

    Time frame: within 2 weeks

    Blood gas analyzer will be used to measure the partial arterial pressure of oxygen (PaO2)for all participants in all groups before and after the treatment program.

    The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.

    the normative value of Pao2 is 1.7-13.3 KPa.

  7. Measurement of the Bicarbonate (HCO3)

    Time frame: within 2 weeks

    Blood gas analyzer will be used to measure the Bicarbonate (HCO3) for all participants in all groups before and after the treatment program.

    The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.

    The normative value of HCO3 is 22-26 mmol/L.

  8. Measurement of oxygen saturation (SO2)

    Time frame: within 2 weeks

    Blood gas analyzer will be used to measure oxygen saturation (SO2) for all participants in all groups before and after the treatment program.

    The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.

    The normative value of SO2 is 95-100%..

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 24, 2024
Registry last updated
Apr 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.